Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial
暂无分享,去创建一个
G. Morgan | W. Gregory | M. Drayson | N. Russell | M. Jenner | F. Davies | G. Cook | G. Jackson | D. Cairns | M. Kaiser | R. Owen | M. Garg | C. Pawlyn | J. Lindsay | K. Karunanithi | John R. Jones | Anna Waterhouse | B. Kishore | C. Williams | A. Striha | C. Collett | Craig Taylor | Jamie N Wilson